A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2-Reference-Cited by-同舟云学术

A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2

Published:2019-01-18 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Herrmann Amanda C.,Im Jin S.,Pareek Sumedha,Ruiz-Vasquez Wilfredo,Lu Sijie,Sergeeva Anna,Mehrens Jennifer,He Hong,Alatrash Gheath,Sukhumalchandra Pariya,St. John Lisa,Clise-Dwyer Karen,Zha Dongxing,Molldrem Jeffrey J.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. An update of current treatments for adult acute myeloid leukemia;Dombret;Blood,2016

2. The new perspectives of targeted therapy in acute myeloid leukemia;Walasek;Adv Clin Exp Med.,2018

3. Use of FLT3 inhibitors in acute myeloid leukemia remission induction or salvage therapy: systematic review and meta-analysis;Yang;Cancer Manag Res.,2018

4. Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia;Jurisic;J Genet.,2009

5. FDA Approval: gemtuzumab ozogamicin for the treatment of adults with newly-diagnosed CD33-positive acute myeloid leukemia;Jen;Clin Cancer Res.,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?;Expert Review of Hematology;2023-10-17

2. Challenges and solutions for therapeuticTCR‐based agents;Immunological Reviews;2023-07-16

3. A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies;Blood;2022-08-25

4. Therapeutic bispecific antibodies against intracellular tumor antigens;Cancer Letters;2022-07

5. Biology and Clinical Evaluation of T/NK Cell Engagers;Cancer Drug Discovery and Development;2022